Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
AstraZeneca UK Limited seeks a Senior Director to lead global Safety Epidemiology strategy and deliverables in collaboration with Global Patient Safety and Regulatory partners. You will shape study plans, ensure PARCS alignment, and guide a team of 10–20 epidemiologists and external resources.
The role requires PhD in epidemiology or equivalent with extensive pharma experience, demonstrated leadership, and strong English communication.
The Senior Director develops and leads global pharmacovigilance epidemiology strategy and deliverables in partnership with Patient Safety and Regulatory leaders, providing scientific guidance as needed. The role also coordinates with local markets on mandated PARCS that require local real-world evidence. Working across Global Patient Safety, Regulatory, Global and Local Medical, and R&D, the Senior Director shapes strategic epidemiology and pharmacovigilance study plans and ensures that studies are designed and delivered in accordance with regulatory requirements and anticipated requests from the EMA, FDA and other health authorities.
Provide line management for Safety Epidemiology team members, including:
The Senior Director will lead a team of 10‑20 epidemiologists and oversee contracted resources as needed.
AstraZeneca is a global, science‑led, patient‑focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world's most serious diseases. But we're more than one of the world's leading pharmaceutical companies. At AstraZeneca, we are pioneering new frontiers by identifying and treating patients earlier, working towards the aim of eliminating cancer as a cause of death.
Come and join our AZ team where you will play a pivotal role in this exciting period of development!! AstraZeneca's Safety Epidemiology team is a global group of PhD‑trained pharmacoepidemiologists with expertise in evidence synthesis and analytics. The team plans and delivers R&D safety epidemiology activities that inform the benefit‑risk profiles of nearly 100 marketed and pipeline products. These activities include local and global post‑authorisation regulatory commitment studies (PARCS) submitted to health authorities such as the FDA and EMA. As study leads, the team ensures that PARCS design, execution, analysis and reporting meet rigorous scientific standards and agreed timelines. It is a pivotal scientific leadership role within Global Patient Safety, accountable for the strategic, scientific and operational delivery of safety Epidemiology contributions across AstraZeneca's therapeutic portfolio. The role will embed AI into routine workflows to improve the efficiency and cost‑effectiveness of licence‑to‑operate activities, including PASS and PMS, while strengthening earlier, high‑value epidemiological contributions where appropriate, to earlier‑stage delivery activities such as predictive safety, target product profiles and clinical study design.
When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life‑changing medicines. In‑person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.
Competitive salary and benefits package on offer. The successful candidate will have access to a flexible employee benefits fund, including holiday purchase and flexible time off, pension contributions, Share Save Plans, A performance recognition scheme and a competitive, generous remuneration package.